Page last updated: 2024-08-05 10:47:35

dihydroxy monocarboxylic acid

Any hydroxy monocarboxylic acid carrying at least two hydroxy groups.

ChEBI ID: 35972

Members (19)

MemberDefinitionRole
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acidA dihydroxy monocarboxylic acid that is N-isopropylindole which is substituted at position 3 by a p-fluorophenyl group and at position 2 by a 6-carboxy-3,5-dihydroxyhex-1-en-1-yl group. It has four possible diastereoisomers.(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
1,4-dihydroxy-2-naphthoic acidA naphthoic acid that is 2-naphthoic acid substituted by hydroxy groups at positions 1 and 4.1,4-dihydroxy-2-naphthoic acid
23-hydroxyursolic acidA pentacyclic triterpenoid that is ursolic acid substituted by an additional hydroxy group at position 23. It has been isolated from Lagerstroemia speciosa and Juglans sinensis.23-hydroxyursolic acid
2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acidA pentacyclic triterpenoid that is betulinic acid carrying an additional alpha-hydroxy group at position 2. It has been isolated from Breynia fruticosa.2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acid
3-(3-hydroxyphenyl)-3-hydroxypropanoic acidA dihydroxy monocarboxylic acid that is 3-hydroxypropanoic acid substituted by a 3-hydroxyphenyl group at position 3.3-(3-hydroxyphenyl)-3-hydroxypropanoic acid
5,12-dihydroxy-6,8,14-eicosatrienoic acidA leukotriene obtained by formal dehydrogenation of the 10,11-double bond in leukotriene B4.10,11-dihydroleukotriene B4
9,10-dihydroxystearic acidA hydroxy-fatty acid formally derived from octacecanoic (stearic) acid by hydroxy substitution at positions 9 and 10.9,10-dihydroxyoctadecanoic acid
alpha,beta-dihydroxyisovaleric acidA dihydroxy monocarboxylic acid that is isovaleric acid which is substituted by hydroxy groups at positions 2 and 3.2,3-dihydroxy-3-methylbutanoic acid
atorvastatinA dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.atorvastatin
atractyligenineA diterpenoid isolated from coffee silverskin. It inhibits cutaneous photoaging.atractyligenin
cerivastatin(3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cholesterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity.cerivastatin
epi-maslinic acidA pentacyclic triterpenoid that is 3alpha-hydroxy epimer of maslinic acid. Isolated from Prunella vulgaris and Isodon japonicus, it exhibits anti-inflammatory activity.epi-maslinic acid
hederageninA sapogenin that is olean-12-en-28-oic acid substituted by hydroxy groups at positions 3 and 23 (the 3beta stereoisomer).hederagenin
l 154819A polyketide obtained by hydrolysis of the pyranone ring of lovastatin.mevinolinic acid
leukotriene b4A leukotriene composed of (6Z,8E,10E,14Z)-icosatetraenoic acid having (5S)- and (12R)-hydroxy substituents. It is a lipid mediator of inflammation that is generated from arachidonic acid via the 5-lipoxygenase pathway.leukotriene B4
leukotriene b5A leukotriene composed of (6Z,8E,10E,14Z,17Z)-icosapentaenoic acid carrying (5S)- and (12R)-hydroxy substituents.leukotriene B5
maslinic acidA pentacyclic triterpenoid that is olean-12-ene substituted by hydroxy groups at positions 2 and 3 and a carboxy group at position 28 (the 2alpha,3beta stereoisomer). It is isolated from Olea europaea and Salvia canariensis and exhibits anti-inflammatory, antioxidant and antineoplastic activity.maslinic acid
pitavastatinA dihydroxy monocarboxylic acid that is (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]hept-6-enoic acid in which the two hydroxy groups are located at positions 3 and 5 (the 3R,5S-stereoisomer). Used as its calcium salt for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise.pitavastatin
rosuvastatinA dihydroxy monocarboxylic acid that is (6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl} hept-6-enoic acid carrying two hydroxy substituents at positions 3 and 5 (the 3R,5S-diastereomer).rosuvastatin

Research

Studies (14,317)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19901,828 (12.77)18.7374
1990's2,381 (16.63)18.2507
2000's4,355 (30.42)29.6817
2010's4,593 (32.08)24.3611
2020's1,160 (8.10)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials2,588 (17.01%)5.53%
Reviews984 (6.47%)6.00%
Case Studies479 (3.15%)4.05%
Observational82 (0.54%)0.25%
Other11,086 (72.84%)84.16%